The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
TWST.COM Logo
  • Home
  • Experts
  • Reports
  • Products
  • News
  • About Us
  • Series
    • General Investing
    • Financial Services
    • Consumer
    • Industry & Services
    • Natural Resources
    • Healthcare
    • Technology
  • Contact Us

Pharmacyclics, Inc.

Related Interviews

Stretched Valuations in Biotech Require Cautious Approach
December 15, 2014

Managing a Growth Portfolio with a Focus on Company-Specific Metrics
September 08, 2014

Cancer Immunotherapy a Top Focus in Biotechnology Sector
August 20, 2014

Biotechnology Capital Inflows Reach Historic Highs
April 07, 2014

Investing in Health Care Innovation
April 30, 2013

High Success Rates and Significant M&A in the Antibody Space
April 16, 2013

Hepatitis C Therapies Propel Growth in Biotech
August 30, 2012

Internet Interactivity Trends In 2011 - Brian J. Pitz - Ubs Investment Bank
April 04, 2011

Continued M&a Activity In The Specialty Pharma Space - David Amsellem - Piper Jaffray & Co.
November 15, 2010

A Close Look At Therapeutics Within Biotech - Matthew L. Kaplan - Ladenburg Thalmann & Co.
April 05, 2010

DEPARTMENT STORES, DISCOUNTERS & DOLLAR STORES: SHARI EBERTS - J.P. MORGAN CHASE
April 05, 2004

J.raymond Elliot - Zimmer Holdings Inc (zmh)
October 12, 2001

Emerging Pharamaceutical Companies : Corey Davis - Chase H&q
January 13, 2000

Stephen A. Hill - Arqule Inc (arql)
January 13, 2000

Roundtable Forum: Major Chemicals
December 20, 1999

Cart

Latest News

NASDAQ:CMPS — Why Compass Pathways Is Surging Following White House Executive Order
“Be Greedy When Others Are Fearful” Said Warren Buffett And These BDC Analysts Have The Picks
Lightwave Logic (NASDAQ:LWLG) Surges on Tower Semiconductor Partnership to Scale AI-Ready Polymers

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

Subscribe now!

Sign Up For Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews

Buying on Market Overreactions: SS&C, Equifax and Cigna

Brent Fredberg

Published September 21, 2026 in Investing Strategies: Value

Companies covered: EFX CI SSNC

Buy ($25)

Lennar and KKR: Quality Businesses Trading at Attractive Valuations

Larry Pitkowsky
Artie Kwok

Published September 21, 2026 in Investing Strategies: Value

Companies covered: LEN MRP KKR

Buy ($25)

Beaten Down Valuations Create Buying Opportunities in U.S. Healthcare

Nick Kirrage

Published September 21, 2026 in Investing Strategies: Value

Companies covered: ELV CNC MOH FDS TX

Buy ($25)

Most Popular Reports

Investing Strategies: Value

Published September 21, 2026

Topics covered: Investing Strategies: Value

Buy ($175)

Construction, Building Materials, Waste Management and Chemicals

Published September 04, 2026

Topics covered: Construction, Building Materials, Waste Management and Chemicals

Buy ($175)

Investing Strategies: Mid Cap and Smid Cap

Published August 13, 2026

Topics covered: Investing Strategies: Mid Cap and Smid Cap

Buy ($175)

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
IBM (International Business Machines Corp.)
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the President and CEO: Trex Company Inc. (NYSE:TREX)
Interview with the CEO: Legence Corp. (NASDAQ:LGN)
Interview with the President and CEO: Latham Group, Inc. (NASDAQ:SWIM)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Buying on Market Overreactions: SS&C, Equifax and Cigna
Lennar and KKR: Quality Businesses Trading at Attractive Valuations
Beaten Down Valuations Create Buying Opportunities in U.S. Healthcare
ANALYST INTERVIEWS
Clariant and Air Products Could Benefit as Middle East Disruptions Ease
Qnity’s Electronic Chemicals Franchise Looks Undervalued
APi Group and Ferguson Are Well-Positioned for AI Buildout Going Forward
Subscribe Today!
Since 1963
© The Wall Street Transcript 2016, 2026
Terms and Conditions
Privacy Policy
 
 
https://www.twst.com/wp-admin/admin-ajax.php https://www.twst.com/wp-admin/admin-ajax.php
  • Join now for free!
  • Already a member?

or create an account with a social network.

Join with Facebook
Join with Twitter
Join with Google

Forgot password?

or login using a social network


Log in with Facebook
Log in with Twitter
Log in with Google